CClinicalTrials.gg
CompletedNCT00692068Updated Jun 6, 2008

Relations Between Residual Renal Function and Oxidative and Carbonyl Stress in Peritoneal Dialysis Patients

An observational study in Chronic Renal Failure, sponsored by Iwata City Hospital. Completed at 1 site in Japan. Open to participants aged 10 Years to 90 Years. Per ClinicalTrials.gov, last updated 2008-06-06.

Sponsored by Iwata City Hospital · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Ages
10 Years to 90 Years
Sex
All
01

Study summary

Residual renal function is reported to contribute to the survival and cardiovascular disease of peritoneal dialysis patients. Oxidative and carbonyl stress are increased in peritoneal dialysis patients and are associated with cardiovascular risk. The aim of this study was to determine the relations between residual renal function and oxidative and carbonyl stress in peritoneal dialysis patients.

02

Conditions studied

  • Chronic Renal Failure

Keywords

  • residual renal function
  • oxidative stress
  • carbonyl stress
  • peritoneal dialysis
03

In context

Kidney Failure, Chronic

2,085 studies on the registry are indexed under Kidney Failure, Chronic; 260 are open to participants now.

Browse Kidney Failure, Chronic studies →

Lead sponsor

This is the only study on the registry with Iwata City Hospital as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

single dialysis center

Inclusion criteria

  • chronic renal failure on peritoneal dialysis

Exclusion criteria

Exclusion Criteria:

  • malignancy, peritonitis
05

Study design

Observational model
Case-control
Time perspective
Prospective

Groups and cohorts

  • A

    with residual renal function

  • B

    without residual renal function

06

Study locations

1 site
  • Iwata City Hospital
    Iwata, Shizuoka 438-8550, Japan
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 6, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00692068
Lead sponsor
Iwata City Hospital
Collaborators
University of Shizuoka, Hamamatsu University
First posted
Jun 6, 2008
Last update
Jun 6, 2008

Study contacts

Ryuichi Furuya, M.D.
study chair · Iwata City Hospital
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion